Maosheng Duan - Concepedia

Author

Maosheng Duan

GlaxoSmithKline (United States)

Also Known As

Duan, Maosheng, Maosheng Duan

Publications

574

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)Research Triangle Park Foundation The Ohio State University GlaxoSmithKline (United Kingdom)

About

Maosheng Duan is an author at GlaxoSmithKline (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	391
2	Natural Sciences	10	10	266
3	Biochemistry	9	9	240
4	Biomolecular Engineering	3	3	67
5	Engineering	2	2	24

Maosheng Duan

Publications

538

Citations

H-Index

Page 1

	Year	Citations
A Convergent Three-Component Total Synthesis of the Powerful Immunosuppressant (−)-Sanglifehrin A Leo A. Paquette, Maosheng Duan, Ingo Konetzki, Journal of the American Chemical Society	2002	88
Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease Charles Z. Ding, Yong-Kang Zhang, Xianfeng Li, Bioorganic & Medicinal Chemistry Letters BiochemistryBiological EvaluationsMedicineAntiviral Drug DevelopmentAntiviral Therapy	2010	46
Novel Spiroketal Pyrrolidine GSK2336805 Potently Inhibits Key Hepatitis C Virus Genotype 1b Mutants: From Lead to Clinical Compound Wieslaw M. Kazmierski, Andrew Maynard, Maosheng Duan, Journal of Medicinal Chemistry Rapid Clinical ProgressInteraction ModelViral HepatitisMedicineAntiviral Drug Development	2014	43
Enantioselective Total Synthesis of the Cyclophilin-Binding Immunosuppressive Agent Sanglifehrin A This work was financially supported by Eli Lilly and Company and a Robert Mayer Graduate Fellowship (to M.D.). We thank Prof. K. C. Nicolaou for providing authentic spectra of 1. Maosheng Duan, Leo A. Paquette Angewandte Chemie International Edition Bioorganic ChemistryMolecular BiologySubsequent LinkupChemical BiologySynthetic Immunology	2001	42
Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties Xianfeng Li, Suoming Zhang, Yong-Kang Zhang, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNovel P4-benzoxaborole MoietiesNatural SciencesMedicineAntiviral Drug Development	2011	42
Discovery of Novel Urea-Based Hepatitis C Protease Inhibitors with High Potency against Protease-Inhibitor-Resistant Mutants Wieslaw M. Kazmierski, Robert Hamatake, Maosheng Duan, Journal of Medicinal Chemistry ImmunologyPharmacotherapyAntiviral DrugDrug ResistanceMedicinal Chemistry	2012	39
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease Xianfeng Li, Yong-Kang Zhang, Yang Liu, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineNatural SciencesNew Acylsulfamoyl BenzoxaborolesAntiviral Drug Development	2010	30
Novel 4,4-Disubstituted Piperidine-Based C–C Chemokine Receptor-5 Inhibitors with High Potency against Human Immunodeficiency Virus-1 and an Improved human Ether-a-go-go Related Gene (hERG) Profile Wieslaw M. Kazmierski, Don L. Anderson, Christopher Aquino, Journal of Medicinal Chemistry Strong Anti-hiv PotencyImmunologyClinical Compound 122PharmacotherapyAntiviral Drug	2011	29
Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2* Wieslaw M. Kazmierski, Jennifer Peckham, Maosheng Duan, Current Medicinal Chemistry - Anti-Infective Agents ImmunologyPharmacotherapyAntiviral DrugPharmaceutical ChemistryMedicinal Chemistry	2005	22
Synthesis of the tripeptide (C1–N12) and hydroxylated hexadecene (C26–C41) domains of sanglifehrin A and C Leo A. Paquette, Ingo Konetzki, Maosheng Duan Tetrahedron Letters Sanglifehrin ABiochemistryNatural SciencesOrganic ChemistryPeptide Science	1999	21

Page 1